Vasa Therapeutics

PharmaceuticalsSeedEncinitas, USvasatherapeutics.com

Latest round

Seed

Last raised

Dec 2023

Total raised

$3.3M

Investors

3

About Vasa Therapeutics

Based in California, US, and founded in 2019 by Chief Executive Officer Artur Plonowski, Vasa Therapeutics, Inc. operates as a healthcare-based company developing therapies that target the pathophysiology of cardiovascular aging. In January 2024, Vasa Therapeutics, Inc. Vasa Therapeutics, Inc. has developed transformative therapies for diseases related to cardiovascular aging, heart failure, peripheral artery disease (PAD), and sarcopenia. The company offers VS-041, which is a medicine-based treatment for heart failure with preserved ejection fraction (HFpEF). In addition, the firm provides apelin peptide analogs, which are for obese patients at risk for skeletal muscle loss or cardiovascular disease. Vasa Therapeutics, Inc. offers an inhibitor of camKIId, a solution for heart failure and life-threatening arrhythmias.

Who invested in Vasa Therapeutics

3 investors across 1 round

See all investors in Vasa Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 22, 2023

    Amount

    $3.3M

    Investors

    Locked

Questions about Vasa Therapeutics

Who invested in Vasa Therapeutics?

Vasa Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vasa Therapeutics raised?

Vasa Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Vasa Therapeutics last raise money?

Vasa Therapeutics's most recent round on record is a Seed, in Dec 2023.

What does Vasa Therapeutics do?

Based in California, US, and founded in 2019 by Chief Executive Officer Artur Plonowski, Vasa Therapeutics, Inc.

Where is Vasa Therapeutics headquartered?

Vasa Therapeutics is headquartered in Encinitas, US.

Which VCs invest in companies like Vasa Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vasa Therapeutics's stage. Their profiles are linked below.

Raising like Vasa Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.